| Stage | UCTT | % of rev | NVDA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $759M | 100.00% | $96.2B | 100.00% | NVDA ×126.77 |
| Gross profit | $128M | 16.92% | $72.1B | 74.98% | NVDA +58.1pp |
| Operating income | $54M | 7.08% | $63.7B | 66.24% | NVDA +59.2pp |
| Pre-tax income | $51M | 6.73% | $71.5B | 74.32% | NVDA +67.6pp |
| Net income | $41M | 5.38% | $59.7B | 62.03% | NVDA +56.7pp |
| Stage | UCTT | NVDA | Gap · A − B |
|---|---|---|---|
| Revenue | $759M100.00% | $96.2B100.00% | NVDA ×126.77 |
| Gross profit | 16.92%$128M | 74.98%$72.1B | NVDA +58.1pp |
| Operating income | 7.08%$54M | 66.24%$63.7B | NVDA +59.2pp |
| Pre-tax income | 6.73%$51M | 74.32%$71.5B | NVDA +67.6pp |
| Net income |
| 5.38%$41M |
| 62.03%$59.7B |
| NVDA +56.7pp |
No shared counterparties.